Neurological Genetic tests in Dubai & UAE

Compare available Neurological Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic test prices

Showing 1–15 of 49 matching tests.

Neurological Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5711 AFG3L2 Gene Spastic Ataxia Type 5, Autosomal Recessive Genetic Test This test identifies pathogenic variants in the AFG3L2 gene associated with autosomal recessive spastic ataxia type 5.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Biallelic pathogenic variants in the AFG3L2 gene"] Parameters [] Preparation ["No special preparation such as fasting is required", "Mandatory pre-test genetic counselling session is needed"] Indications ["Patients presenting with clinical signs of progressive spastic paraparesis and cerebellar atrophy on neuroimaging", "Family history suggestive of autosomal recessive spastic ataxia type 5"] Measurement technique Confirm with laboratory Codes LOINC: 81263-4 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the AFG3L2 gene associated with autosomal recessive spastic ataxia type 5.
TEST-4204 ANO3 Gene (DYT24) Genetic Test This test evaluates the ANO3 gene for pathogenic variants associated with autosomal dominant dystonia type 24.	Whole blood (2–5 mL EDTA), extracted DNA (≥1 µg), or FTA card (3 dried blood spots)	3–4 weeks (expedited 2-week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANO3 gene coding region", "ANO3 gene splice sites", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Individuals with early-onset cervical or laryngeal dystonia", "Individuals with a family history of dystonia", "Individuals with unexplained movement disorders"] Measurement technique Confirm with laboratory Codes LOINC: 102022-8 ICD-10: G24.1 Clinical summary This test evaluates the ANO3 gene for pathogenic variants associated with autosomal dominant dystonia type 24.
TEST-4618 ARHGEF9 Gene-Related Hyperekplexia & EIEE8 Genetic Test This genetic test identifies pathogenic variants in the ARHGEF9 gene associated with hereditary hyperekplexia and early infantile epileptic encephalopathy type 8.	Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARHGEF9 gene", "Copy Number Variants (CNVs) in ARHGEF9"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history and family pedigree during pre-genetic counselling"] Indications ["Suspected hereditary hyperekplexia", "Suspected early infantile epileptic encephalopathy type 8 (EIEE8)", "Family history of ARHGEF9-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G25.8, G40.8 Clinical summary This genetic test identifies pathogenic variants in the ARHGEF9 gene associated with hereditary hyperekplexia and early infantile epileptic encephalopathy type 8.
TEST-5541 ARX Gene Partington Syndrome Genetic Test This test sequences the ARX gene to detect pathogenic variants associated with Partington syndrome.	Peripheral Whole Blood (3-5 mL in EDTA) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARX gene sequence", "Pathogenic variants in ARX gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all current medications"] Indications ["Suspected ARX-related Partington syndrome", "X-linked intellectual disability", "Family history of Partington syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 10386-3 ICD-10: Q87.8 Clinical summary This test sequences the ARX gene to detect pathogenic variants associated with Partington syndrome.
TEST-5800 ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test This test detects CAG repeat expansions in the ATXN7 gene, which are the cause of Spinocerebellar Ataxia Type 7.	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG repeat expansion in the ATXN7 gene"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Suspected Spinocerebellar Ataxia Type 7", "Progressive ataxia with family history"] Measurement technique Confirm with laboratory Codes LOINC: 92747-7 ICD-10: G11.8 Clinical summary This test detects CAG repeat expansions in the ATXN7 gene, which are the cause of Spinocerebellar Ataxia Type 7.
TEST-4472 CACNA1A Gene Analysis (Familial Hemiplegic Migraine Type 1) Test This test identifies pathogenic variants in the CACNA1A gene associated with Familial Hemiplegic Migraine Type 1 (FHM1). It uses Next Generation Sequencing (NGS) for comprehensive...	Peripheral Whole Blood or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1A gene", "Point mutations", "Indels", "Copy number variants"] Parameters [] Preparation [] Indications ["Molecular confirmation of suspected Familial Hemiplegic Migraine Type 1", "Risk assessment for family members of a confirmed FHM1 proband"] Measurement technique Confirm with laboratory Codes LOINC: 94244-1 ICD-10: G43.10 Clinical summary This test identifies pathogenic variants in the CACNA1A gene associated with Familial Hemiplegic Migraine Type 1 (FHM1). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-5896 CACNA1A Gene Spinocerebellar Ataxia Type 6 (SCA6) Genetic Test This test identifies pathogenic variants within the CACNA1A gene, confirming a diagnosis of autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6).	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CACNA1A gene sequence", "Copy number variations in CACNA1A gene"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["Pre-test genetic counselling recommended", "Provide detailed clinical history", "No special fasting required", "Inform phlebotomist of anticoagulant therapy"] Indications ["Family history of SCA6", "Suggestive clinical symptoms of SCA6", "Need for definitive molecular confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 82996-8 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants within the CACNA1A gene, confirming a diagnosis of autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6).
TEST-3837 CDKL5 Deficiency Disorder (Angelman‑like Syndrome) Genetic Test This test identifies genetic variants in the CDKL5 gene associated with early-onset epileptic encephalopathy resembling Angelman syndrome.	Whole Blood (peripheral) / Dried Blood Spot on FTA Card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CDKL5 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Patients must continue all prescribed anti-epileptic medications"] Indications ["Suspected CDKL5 deficiency disorder", "Early-onset epileptic encephalopathy", "Clinical features resembling Angelman syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94121-4 ICD-10: G40.42 Clinical summary This test identifies genetic variants in the CDKL5 gene associated with early-onset epileptic encephalopathy resembling Angelman syndrome.
TEST-3915 CELF6 Gene Genetic Test for Autism Spectrum Disorder This test identifies pathogenic variants in the CELF6 gene associated with Autism Spectrum Disorder (ASD).	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CELF6 gene", "Single-nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation [] Indications ["Diagnosis of Autism Spectrum Disorder", "Family history of ASD", "Genetic counseling for ASD"] Measurement technique Confirm with laboratory Codes LOINC: 94473-2 ICD-10: F84.0 Clinical summary This test identifies pathogenic variants in the CELF6 gene associated with Autism Spectrum Disorder (ASD).
TEST-5603 CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Testing Test This genetic test identifies pathogenic variants in the CLP1 gene associated with pontocerebellar hypoplasia type 10.	Whole blood (EDTA), or single drop on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLP1 gene"] Parameters [] Preparation ["No special fasting or medication adjustments are needed unless instructed otherwise."] Indications ["Clinical suspicion of pontocerebellar hypoplasia type 10", "Family risk assessment", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G31.89 Clinical summary This genetic test identifies pathogenic variants in the CLP1 gene associated with pontocerebellar hypoplasia type 10.
TEST-5336 COL6A6 Gene Myopathy (COL6A6-Related) Genetic Test This test analyzes the COL6A6 gene for pathogenic variants associated with congenital myopathies and muscular dystrophies.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL6A6 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNV)"] Parameters [] Preparation ["Complete a pre-test genetic counselling session", "Provide clinical history and list of current medications", "Parental consent required for minors"] Indications ["Suspected congenital myopathy", "Suspected muscular dystrophy", "Family history of COL6A6-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81214-2 ICD-10: G71.0, G71.2 Clinical summary This test analyzes the COL6A6 gene for pathogenic variants associated with congenital myopathies and muscular dystrophies.
TEST-5712 CPT1C Gene (SPG73) Genetic Test This test identifies pathogenic variants in the CPT1C gene associated with Hereditary Spastic Paraplegia Type 73 (SPG73).	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CPT1C gene", "Copy number analysis of the CPT1C gene"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of all current medications, including antispasticity drugs (e.g., baclofen, tizanidine)."] Indications ["Diagnosis of Hereditary Spastic Paraplegia Type 73 (SPG73)", "Family planning for individuals with a family history of SPG73", "Confirmation of clinical suspicion of SPG73"] Measurement technique Confirm with laboratory Codes LOINC: 21665-5 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the CPT1C gene associated with Hereditary Spastic Paraplegia Type 73 (SPG73).
TEST-5760 CWF19L1 Gene Spinocerebellar Ataxia Type 17 (Autosomal Recessive) Genetic Test This test identifies pathogenic variants within the CWF19L1 gene associated with autosomal recessive spinocerebellar ataxia type 17 (SCA17).	Whole blood (EDTA), saliva, or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CWF19L1 gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab if on anticoagulant therapy"] Indications ["Clinical suspicion of autosomal recessive spinocerebellar ataxia type 17", "Family history of SCA17", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82154-2 ICD-10: G11.9 Clinical summary This test identifies pathogenic variants within the CWF19L1 gene associated with autosomal recessive spinocerebellar ataxia type 17 (SCA17).
TEST-4689 DARS2 Gene Leukoencephalopathy with Brainstem & Spinal Cord Involvement & Lactate Elevation (LBSL) Genetic Test This genetic test identifies pathogenic variants in the DARS2 gene, confirming a diagnosis of LBSL.	Peripheral Whole Blood (EDTA) or Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DARS2 gene", "Deletion/Duplication analysis of the DARS2 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of LBSL", "Progressive neurological symptoms consistent with leukodystrophy", "Elevated lactate levels"] Measurement technique Confirm with laboratory Codes LOINC: 81369-8 ICD-10: E74.81 Clinical summary This genetic test identifies pathogenic variants in the DARS2 gene, confirming a diagnosis of LBSL.
TEST-4751 DCX Gene Analysis (X-Linked Lissencephaly & Subcortical Band Heterotopia) Genetic Test This test analyzes the DCX gene to identify mutations associated with X-linked lissencephaly and subcortical band heterotopia.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DCX gene sequence", "Copy Number Variants (CNVs) in DCX gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected X-linked lissencephaly", "Suspected subcortical band heterotopia", "Family history of DCX-related disorders", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 82272-8 ICD-10: Q04.3 Clinical summary This test analyzes the DCX gene to identify mutations associated with X-linked lissencephaly and subcortical band heterotopia.

Category overview

Neurological Genetic: overview

Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurological Genetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurological genetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.